Total Payments
$260,459
2024 Payments
$11,846
Companies
44
Transactions
984
Medicare Patients
7,338
Medicare Billing
$544,003
Payment Breakdown by Category
Other$230,217 (88.4%)
Food & Beverage$19,369 (7.4%)
Travel$9,868 (3.8%)
Education$704.92 (0.3%)
Consulting$300.00 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $230,217 | 121 | 88.4% |
| Food and Beverage | $19,369 | 803 | 7.4% |
| Travel and Lodging | $9,868 | 49 | 3.8% |
| Education | $704.92 | 10 | 0.3% |
| Consulting Fee | $300.00 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $128,411 | 210 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $103,583 | 273 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $15,846 | 65 | $0 (2024) |
| Abbott Laboratories | $2,917 | 55 | $0 (2024) |
| Medtronic Vascular, Inc. | $2,013 | 9 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $1,312 | 124 | $0 (2024) |
| BOSTON SCIENTIFIC CORPORATION | $921.90 | 9 | $0 (2018) |
| Edwards Lifesciences Corporation | $667.93 | 11 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $617.70 | 34 | $0 (2024) |
| PFIZER INC. | $556.87 | 33 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $11,846 | 78 | Amgen Inc. ($7,727) |
| 2023 | $34,015 | 118 | Amgen Inc. ($18,859) |
| 2022 | $31,438 | 139 | Janssen Pharmaceuticals, Inc ($16,008) |
| 2021 | $47,192 | 132 | Amgen Inc. ($26,189) |
| 2020 | $9,215 | 66 | Amgen Inc. ($4,643) |
| 2019 | $39,742 | 132 | Janssen Pharmaceuticals, Inc ($19,028) |
| 2018 | $38,686 | 129 | Janssen Pharmaceuticals, Inc ($25,022) |
| 2017 | $48,326 | 190 | Amgen Inc. ($28,604) |
All Payment Transactions
984 individual payment records from CMS Open Payments — Page 1 of 40
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $10.76 | General |
| Category: Cardiology | ||||||
| 12/11/2024 | ShockWave Medical, Inc | Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) | Food and Beverage | In-kind items and services | $57.64 | General |
| Category: Lithoplasty | ||||||
| 11/22/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $11.98 | General |
| Category: Cardiology | ||||||
| 11/01/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $9.53 | General |
| Category: DIABETES | ||||||
| 09/27/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $4.91 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/24/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,800.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $8.41 | General |
| Category: DIABETES | ||||||
| 09/13/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $10.52 | General |
| Category: Cardiology | ||||||
| 09/12/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $71.70 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/11/2024 | Amgen Inc. | Repatha (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,800.00 | General |
| Category: Cardiology | ||||||
| 09/11/2024 | Amgen Inc. | Repatha (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $467.00 | General |
| Category: Cardiology | ||||||
| 09/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $5.16 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $2.59 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $1.36 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/05/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $77.13 | General |
| Category: Cardiology | ||||||
| 09/05/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.57 | General |
| Category: Cardiovascular | ||||||
| 08/23/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $9.98 | General |
| Category: Cardiology | ||||||
| 08/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $10.29 | General |
| Category: DIABETES | ||||||
| 08/16/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $3.23 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/14/2024 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 08/13/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $3.21 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/13/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $2.50 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.77 | General |
| Category: DIABETES | ||||||
| 07/19/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: Cardiology | ||||||
| 06/28/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $17.24 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 1,481 | 1,681 | $630,953 | $121,126 |
| 2022 | 21 | 1,665 | 2,095 | $681,409 | $139,129 |
| 2021 | 26 | 2,430 | 2,907 | $681,687 | $175,949 |
| 2020 | 24 | 1,762 | 2,296 | $337,967 | $107,799 |
Total Patients
7,338
Total Services
8,979
Medicare Billing
$544,003
Procedure Codes
121
All Medicare Procedures & Services
121 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 166 | 166 | $197,751 | $33,428 | 16.9% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 45 | 46 | $75,697 | $20,700 | 27.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 139 | 151 | $18,708 | $9,997 | 53.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 65 | 77 | $22,907 | $6,675 | 29.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 125 | 139 | $11,376 | $6,323 | 55.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 110 | 111 | $93,140 | $5,628 | 6.0% |
| 93459 | Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | Facility | 2023 | 20 | 22 | $29,415 | $4,921 | 16.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 62 | 75 | $18,105 | $4,491 | 24.8% |
| 93460 | Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 12 | 12 | $18,109 | $3,492 | 19.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 18 | 18 | $8,118 | $3,073 | 37.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 32 | 32 | $6,911 | $2,723 | 39.4% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Facility | 2023 | 54 | 134 | $8,139 | $2,533 | 31.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 15 | 16 | $5,824 | $2,137 | 36.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 15 | 15 | $4,034 | $2,128 | 52.7% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Facility | 2023 | 33 | 33 | $28,394 | $2,119 | 7.5% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 237 | 293 | $8,988 | $1,756 | 19.5% |
| 33285 | Insertion of heart rhythm monitor under skin | Facility | 2023 | 22 | 22 | $4,292 | $1,522 | 35.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 11 | 11 | $1,903 | $1,232 | 64.8% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 11 | 11 | $8,323 | $909.42 | 10.9% |
| 93571 | Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | Facility | 2023 | 13 | 13 | $13,856 | $734.76 | 5.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 14 | 14 | $1,994 | $702.22 | 35.2% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Facility | 2023 | 26 | 31 | $5,590 | $692.11 | 12.4% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 39 | 39 | $3,590 | $631.73 | 17.6% |
| 33286 | Removal of heart rhythm monitor from under the skin | Facility | 2023 | 12 | 12 | $2,269 | $612.66 | 27.0% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2023 | 38 | 38 | $12,042 | $524.40 | 4.4% |
About Dr. Daniel Lee, MD
Dr. Daniel Lee, MD is a Interventional Cardiology healthcare provider based in Saginaw, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1861472367.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Lee, MD has received a total of $260,459 in payments from pharmaceutical and medical device companies, with $11,846 received in 2024. These payments were reported across 984 transactions from 44 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($230,217).
As a Medicare-enrolled provider, Lee has provided services to 7,338 Medicare beneficiaries, totaling 8,979 services with total Medicare billing of $544,003. Data is available for 4 years (2020–2023), covering 121 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Cardiology
- Location Saginaw, MI
- Active Since 01/19/2006
- Last Updated 11/28/2007
- Taxonomy Code 207RI0011X
- Entity Type Individual
- NPI Number 1861472367
Products in Payments
- Repatha (Biological) $127,721
- XARELTO (Drug) $103,583
- FARXIGA (Drug) $15,150
- Mitra Clip system (Device) $1,611
- PRO CV (Device) $1,476
- GENERAL THERAPIES (Device) $742.36
- LEQVIO (Drug) $738.20
- Corlanor (Drug) $685.42
- JARDIANCE (Drug) $586.59
- ENTRESTO (Drug) $574.25
- BRILINTA (Drug) $491.05
- ELIQUIS (Drug) $419.36
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $353.24
- LifeVest (Device) $339.75
- Azure (Device) $272.80
- Optis Coronary Imaging System (Device) $220.29
- Adempas (Drug) $216.66
- VYNDAQEL (Drug) $214.89
- OPSUMIT (Drug) $204.99
- VERQUVO (Drug) $182.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Interventional Cardiology Doctors in Saginaw
Dr. Safwan Kassas, Md, MD
Interventional Cardiology — Payments: $360,886
Interventional Cardiology $360,886
Dr. Manoj Sharma, Md, MD
Interventional Cardiology — Payments: $10,904
Interventional Cardiology $10,904
Dr. Nishtha Sareen
Interventional Cardiology — Payments: $9,903
Interventional Cardiology $9,903
Dr. Chalapathirao Gudipati, Md, MD
Interventional Cardiology — Payments: $1,750
Interventional Cardiology $1,750
Dr. John Collins, Md, MD
Interventional Cardiology — Payments: $1,191
Interventional Cardiology $1,191
Dr. Kondaramvalappil Ravindran, Md, MD
Interventional Cardiology — Payments: $16.80
Interventional Cardiology $16.80